Evidence map›Paper›PMID 33080630›Full record

ArticleEndoscopy2021

Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database.

Marten A Lantinga, Felix Theunissen, Pieter C J Ter Borg, Marco J Bruno, Rob J T Ouwendijk, Peter D Siersema, Trans.IT foundation study group

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Endoscopy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06670547 (Prospective and Multicenter Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography), which is not on this map. Cited by 52 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06670547 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Prospective and Multicenter Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography

Typeobservational_patient_registrySponsorGermans Trias i Pujol HospitalRan2024 to 2028Enrolled3,000ConditionsCholedocholithiasis, Choledocholithiasis With Acute Cholangitis, Cholangiocarcinoma, Sclerosing CholangitisArmsEndoscopic retrograde cholangiopancreatography (ERCP)
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Impact of COVID-19 Pandemic on Performance of Gastrointestinal Endoscopy.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Marten A Lantinga *Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Felix Theunissen *Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands.
Pieter C J Ter BorgDepartment of Gastroenterology and Hepatology, Ikazia Ziekenhuis, Rotterdam, The Netherlands.
Marco J BrunoDepartment of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands.
Rob J T OuwendijkDepartment of Gastroenterology and Hepatology, Bravis Ziekenhuis, Roosendaal, The Netherlands.
Peter D SiersemaDepartment of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Trans.IT foundation study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 has dramatically affected gastrointestinal endoscopy practice. We aimed to investigate its impact on procedure types, indications, and findings.

methodsWe retrospectively analyzed endoscopies performed in 15 Dutch hospitals by comparing periods 15 March to 25 June of 2019 and 2020 using the prospective Trans.IT database.

resultsDuring lockdown in 2020, 9776 patients underwent endoscopy compared with 19 296 in 2019. Gastroscopies decreased by 57 % (from 7846 to 4467) and colonoscopies by 45 % (from 12219 to 5609), whereas endoscopic retrograde cholangiopancreatography volumes remained comparable (from 578 to 522). Although endoscopy results indicative of cancer decreased (from 524 to 340), the likelihood of detecting cancer during endoscopy increased (2.7 % [95 % confidence interval (CI) 2.5 - 3.0] in 2019 versus 3.5 % [95 %CI 3.1 - 3.9] in 2020;

conclusionsFewer endoscopies were performed during the COVID-19 lockdown, leading to a significant reduction in the absolute detection of cancer. Endoscopies increased rapidly after lockdown, except for colorectal cancer screening.

Indexed as

COVID-19PandemicsDatabases, FactualEndoscopy, GastrointestinalHumansNeoplasmsNetherlandsRetrospective Studies

Identifiers

PMID33080630
PMCPMC7869035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.